![By Mirko Tobias Schaefer [CC-BY-2.0], via Wikimedia Commons](http://www.ptca.org/voice/wp-content/uploads/2013/07/robot_writing_140sq.jpg)
“Writing Robot” by Mirko Tobias Schaefer [CC-BY-2.0], via Wikimedia Commons
The stories are short, usually less than 200 words, but there are thousands. So how come I have never heard about this website that has such an enormous output? And how come I didn’t realize that there were so many healthcare stories out there? Continue reading
Filed under Media Coverage, Web Site
In my newly posted interview with Dr. Ron Caputo of St. Joseph’s Hospital Health Center in Syracuse, New York, he answers my question about what’s changed in the transradial approach over the past five years, as follows:
Dr. Ron Caputo
“Transradial has really exploded. We’ve gone from less than 1% of operators knowing or even being interested in transradial to almost the majority of operators now having heard of or interested in doing it. And a significant number of doctors are using transradial now routinely in their practice. The last number I saw was 1% or 2% five years ago to 15-20% of all PCIs are now being done transradially in the U.S. So that’s big.
“When I talked about transradial five years ago, it was basically like I was doing an evangelical session trying to convince people it’s the right thing to do. Now everywhere I go people are doing it and we’re talking about tips and tricks. Docs have gone from talking about ‘how do you start a radial program’ to ‘these are commonly encountered problems and here’s how you deal with them.’ So it’s really evolved.” Continue reading
Filed under Interviews, Transradial Approach
Sorry Jar-Jar. We all know that Episodes 1-3 of “Star Wars” just didn’t cut it when compared with the original trilogy. Although these prequels were technically more sophisticated, and the digital rendering was way more advanced, the stories were just…boring.
I started the wordplay about “Stent Wars” over a decade ago, a time when the competitive juices of the two device-makers, Boston Scientific and J&J/Cordis, were at an all time peak — each company was heavily marketing their first generation drug-eluting stent and every interventional cardiology meeting was saturated with “Cypher vs. Taxus” messaging. Continue reading
Filed under Drug-Eluting Stents, Stent, Stent Wars
Featured Story at Angioplasty.OrgLike your local educational TV or radio station, Angioplasty.Org relies on help from visitors like you. The grant funding we receive does not fully cover our costs; please consider making a recurring monthly contribution or a one-time donation. |
Top News Headlines
RSS Feed